GlassScriptPhysician profile
Stephen Yonann Liu
NPI 1780975433
$87,267.32
in general payments reported to CMS, 2019-2025
28 companies · $31K in 2025
The $31K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,511 · 2020: $5,954 · 2021: $3,979 · 2022: $21K · 2023: $10K · 2024: $11K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $46K · Food and Beverage: $2,628 · Consulting Fee: $1,926 · Travel and Lodging: $1,888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $45,600.00 |
| Food and Beverage | $2,628.29 |
| Consulting Fee | $1,925.83 |
| Travel and Lodging | $1,887.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Skeletal Dynamics INC | $54,726.75 | 2020-2025 | Implate, Geminus, Align |
| Jazz Pharmaceuticals INC. | $12,737.41 | 2022-2025 | |
| Medical Device Business Services, INC. | $6,716.59 | 2019-2020 | |
| Synthes USA Products LLC | $6,271.64 | 2021-2023 | Lcp, Va-Lcp |
| Liberty Surgical INC. | $2,438.82 | 2020 | |
| Smith+Nephew, INC. | $1,071.75 | 2019-2024 | Stravix Pl, Grafix Pl, Stravix |
| Stryker Corporation | $819.68 | 2019-2025 | Mako, T2, Gamma |
| Medartis INC. | $495.28 | 2019-2022 | |
| Acumed LLC | $320.75 | 2020-2023 | Inframe Implant, Acumed |
| Axogen | $314.97 | 2019-2023 | Avance Nerve Graft |
| Depuy Synthes Sales INC. | $281.08 | 2019-2025 | Va-Lcp |
| Endo Pharmaceuticals INC. | $246.25 | 2019-2023 | Xiaflex |
| Integra Lifesciences Corporation | $162.25 | 2020-2022 | |
| Paladin Technology Solutions | $112.71 | 2024 | |
| Dynasplint Systems INC. | $111.72 | 2019-2023 | Dynasplint |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $98.16 | 2019-2022 | |
| Exsomed Corporation | $83.75 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $63.38 | 2025 | |
| Thommen Medical USA, LLC | $43.22 | 2021 | |
| Bioventus LLC | $38.05 | 2021 | |
| Tela Bio, INC. | $27.40 | 2024 | Ovitex 2s |
| Pacira Pharmaceuticals Incorporated | $24.25 | 2024 | Exparel, Zilretta, Iovera |
| Medline Industries LP | $23.00 | 2024 | |
| Solventum Corporation | $20.89 | 2024 | Prevena |
| Fx Shoulder Solutions, INC | $17.57 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.